The Empire Genomics IGH/MAF DF FISH Probe Kit is intended to detect the t(14;16)(q32;q23) reciprocal translocation involving the IGH and MAF gene regions. MAF is an oncogene that has been found to be commonly over-expressed in multiple myeloma (MM). This translocation has been associated with the more aggressive forms of MM .
Empire Genomics has developed a custom IGH-MAF FISH probe which can be used to detect/confirm a rearrangement of the IGH-MAF gene. The probe comes labeled in orange and green, and generally ships within 24 hours. You can choose to customize the probe to meet your needs, which will ship right after production of the probe is complete (approximately 1 week).
Probe Details


Gene: |
MAF (Orange 5-TAMRA dUTP)
IGH (Green 5-Fluorescein dUTP) |
Loci: |
16q23
14q32 |
Test Kits: |
20 |
bio-equip.cn
The leading supplier of molecular diagnostics for customization and production of FISH probes, aGCH assays and upcoming new technologies to be used by Reference labs, Academic labs, Pharma, CRO’s
and Pharma /Biotech companies around the world.
Our companion Diagnostics will allow you to :
-Validate Bio-markers (signature identification and resistance).
-Identify and qualify the aberration at the Chromosomal level of specific population.
-Follow up the result of therapeutic treatment (monitoring, compound profiling, drug response, patient stratification and safety)
-Compare with the result of your current technology.
-Be translated into the initial phase of your diagnostics development toward new FDA filings (pre-clinical through clinical trial development).